With the appointment of Dr Carsten Linnemann as Federal Minister of Health on 29 July 2026, the question of its political significance has also come into focus.
Whilst hospital reform, the financial situation of the statutory health insurance system and the future of healthcare in Germany remain high priorities, the question arises as to what areas Dr Carsten Linnemann will focus on.
We will closely monitor the progress of the reforms already underway and all new issues.
For medtech companies, investors and decision-makers in the fields of reimbursement, market access and health economics, topics of particular interest include innovative medical device production, hospital financing and hospital planning (service groups).
Changes in the German healthcare market present new challenges, but also new opportunities. We help you identify the implications for your product at an early stage and outline specific courses of action for market access, reimbursement and market development.
Please feel free to contact us for a no-obligation initial consultation.
Author: Healthcare Heads GmbH
Phone: +49 431 800 1470
E-Mail: info@healthcareheads.com